AP News • 8/19/2026 – 8/20/2026

President Trump is expected to nominate Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration (FDA). Overton currently serves as the deputy director of domestic policy at the White House and is a medical doctor. Her nomination is part of Trump's ongoing efforts to fill key positions within his administration, particularly in health-related roles. Dr. Overton has connections to the Make America Healthy Again movement, which aligns with the administration's focus on health policy. If confirmed as FDA commissioner, she will face significant challenges, including addressing ongoing public health issues and managing the regulatory landscape for pharmaceuticals and medical devices. The FDA plays a critical role in ensuring the safety and efficacy of drugs and vaccines, making the leadership position vital during a time of heightened scrutiny over health policies. The announcement of her nomination has been covered by various news outlets, including AP News, NBC News, and Stat News, highlighting her background and the implications of her potential leadership at the FDA. As the nomination process unfolds, Overton's qualifications and approach to the role will be closely examined by lawmakers and the public alike.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.

















